Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Leukemia, Lymphocytic, Chronic, B-Cell 215Lymphoma, Non-Hodgkin 204Lymphoma, Follicular 193Lymphoma, Large B-Cell, Diffuse 180Leukemia 164Hodgkin Disease 160Multiple Myeloma 118Neoplasms 97Leukemia, Myeloid, Acute 87Lymphoma, Mantle-Cell 78Burkitt Lymphoma 67Myelodysplastic Syndromes 64Lymphoma, B-Cell, Marginal Zone 64Lymphoma, T-Cell, Cutaneous 62Breast Neoplasms 62Mycosis Fungoides 55Recurrence 52Lymphoma, B-Cell 50Hematologic Neoplasms 50Sezary Syndrome 43Waldenstrom Macroglobulinemia 41Myeloproliferative Disorders 39Neoplasms, Plasma Cell 38Lung Neoplasms 34Lymphoma, Large-Cell, Immunoblastic 33Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 32Lymphoma, T-Cell, Peripheral 29Leukemia, Hairy Cell 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Meibomian Gland Dysfunction × Lymphoid × Clear all
NCT01692665 2014-02-19

Changes of Keratometric Value and Ocular Aberration After Treatment of Meibomian Gland Dysfunction

Yonsei University

Withdrawn
Lymphoid

Meibomian Gland Dysfunction, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡